SCHEMBL2123091

SCHEMBL2123091

COC(=O)C(C(=O)/C=C/c1cccc(O)c1)C(=O)/C=C/c1cccc(O)c1

nearest known ligand 0.70

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
MMP2 P08253 13/20 0.70
MMP9 P14780 13/20 0.70
MMP13 P45452 2/20 0.70
MMP8 P22894 1/20 0.64
P4HB P07237 1/20 0.53
MMP1 P03956 11/20 0.52
MAOA P21397 1/20 0.49
MAOB P27338 1/20 0.49
HSP90AA1 P07900 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10077695 0.93 MMP2 (0.62) MMP2MMP9MMP13MMP8P4HB
SCHEMBL10084348 0.84 MMP2 (0.73) MMP2MMP9MMP13MMP8MMP1
SCHEMBL2124084 0.83 MMP2 (1.00) MMP2MMP9MMP13MMP8P4HB
SCHEMBL11776540 0.82 MAOB (0.58) MMP2MMP9MMP13MMP8MMP1
SCHEMBL11776532 0.82 MAOB (0.58) MMP2MMP9MMP13MMP8MMP1
SCHEMBL3065424 0.79 CA12 (0.66) MMP2MMP9P4HBMMP1
SCHEMBL2631340 0.79 CA12 (0.66) MMP2MMP9P4HBMMP1
SCHEMBL30676338 0.79 CA12 (0.66) MMP2MMP9P4HBMMP1
SCHEMBL2122001 0.78 MMP2 (1.00) MMP2MMP9MMP13MMP8MAOA
SCHEMBL30540958 0.78 MMP2 (1.00) MMP2MMP9MMP13MMP8MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240360068-A1 CURCUMIN ANALOGUES AS ZINC CHELATORS AND THEIR USES THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2024-10-31 US disclosed
US-20230265041-A1 CURCUMIN ANALOGUES AS ZINC CHELATORS AND TEHIR USES THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2023-08-24 US disclosed
US-11608309-B2 Curcumin analogues as zinc chelators and their uses THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2023-03-21 US disclosed
US-20210322346-A1 CHEMICALLY MODIFIED CURCUMINS FOR USE IN THE PRODUCTION OF LIPOXINS THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2021-10-21 US disclosed
US-20210053905-A1 CURCUMIN ANALOGUES AS ZINC CHELATORS AND THEIR USES THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2021-02-25 US disclosed
US-20210053905-A1 CURCUMIN ANALOGUES AS ZINC CHELATORS AND THEIR USES THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2021-02-25 US disclosed
US-10669227-B2 Curcumin analogues as zinc chelators and their uses THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) 2020-06-02 US disclosed
US-10669227-B2 Curcumin analogues as zinc chelators and their uses THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) 2020-06-02 US disclosed
US-20190254945-A1 INHIBITION OF MELANOGENESIS BY CHEMICALLY MODIFIED CURCUMINS THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2019-08-22 US disclosed
EP-3206488-B1 CURCUMIN ANALOGUES AS ZINC CHELATORS AND THEIR USES UNIV NEW YORK STATE RES FOUND (US) 2019-08-21 EP disclosed
US-9220695-B2 Polyenolic zinc-binding agents (pezbins) actively promote inactivation of cancer stem cells and potentiate cytotoxic anti-tumor drug substances THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2015-12-29 US disclosed
US-9187406-B2 Curcumin analogues as zinc chelators and their uses THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) 2015-11-17 US disclosed
US-9187406-B2 Curcumin analogues as zinc chelators and their uses THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) 2015-11-17 US disclosed
US-20150150834-A1 POLYENOLIC ZINC-BINDING AGENTS (PEZBINS) ACTIVELY PROMOTE INACTIVATION OF CANCER STEM CELLS AND POTENTIATE CYTOTOXIC ANTI-TUMOR DRUG SUBSTANCES CHEM-MASTER INTERNATIONAL, INC. (US) 2015-06-04 US disclosed
US-20150150834-A1 POLYENOLIC ZINC-BINDING AGENTS (PEZBINS) ACTIVELY PROMOTE INACTIVATION OF CANCER STEM CELLS AND POTENTIATE CYTOTOXIC ANTI-TUMOR DRUG SUBSTANCES CHEM-MASTER INTERNATIONAL, INC. (US) 2015-06-04 US disclosed
US-20150073021-A1 CHEMICALLY MODIFIED CURCUMINS AS INHIBITORS OF ANTHRAX LETHAL FACTOR THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2015-03-12 US disclosed
US-20150073021-A1 CHEMICALLY MODIFIED CURCUMINS AS INHIBITORS OF ANTHRAX LETHAL FACTOR THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2015-03-12 US disclosed
US-20120095051-A1 CURCUMIN ANALOGUES AS ZINC CHELATORS AND THEIR USES CHEM-MASTER INTERNATIONAL, INC. 2012-04-19 US disclosed
WO-2010132815-A9 CURCUMIN ANALOGUES AS ZINC CHELATORS AND THEIR USES THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) 2011-01-13 WO disclosed
WO-2010132815-A1 CURCUMIN ANALOGUES AS ZINC CHELATORS AND THEIR USES THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) 2010-11-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150073021-A1 CHEMICALLY MODIFIED CURCUMINS AS INHIBITORS OF ANTHRAX LETHAL FACTOR ANTXR2, APAF1, LITAF MMP2 224/4885MMP9 1104/4885MMP13 928/4885
US-20230265041-A1 CURCUMIN ANALOGUES AS ZINC CHELATORS AND TEHIR USES NFRKB, NFKBIA, NFKB1 MMP2 32/4885MMP9 17/4885MMP13 12/4885
US-20120095051-A1 CURCUMIN ANALOGUES AS ZINC CHELATORS AND THEIR USES NFKBIA, NFKB1, NFKB2 MMP2 19/4885MMP9 12/4885MMP13 11/4885
US-10669227-B2 Curcumin analogues as zinc chelators and their uses NFKBIA, NFKB1, NFKB2 MMP2 19/4885MMP9 12/4885MMP13 11/4885
US-20150150834-A1 POLYENOLIC ZINC-BINDING AGENTS (PEZBINS) ACTIVELY PROMOTE INACTIVATION OF CANCER STEM CELLS AND POTENTIATE CYTOTOXIC ANTI-TUMOR DRUG SUBSTANCES BAZ2B, CEBPZ, BAZ2A MMP2 2518/4885MMP9 1634/4885MMP13 886/4885
US-11608309-B2 Curcumin analogues as zinc chelators and their uses NFKBIA, NFKB1, NFKB2 MMP2 19/4885MMP9 12/4885MMP13 11/4885
US-20210053905-A1 CURCUMIN ANALOGUES AS ZINC CHELATORS AND THEIR USES NFKBIA, NFKB1, NFKB2 MMP2 19/4885MMP9 12/4885MMP13 11/4885
US-20190254945-A1 INHIBITION OF MELANOGENESIS BY CHEMICALLY MODIFIED CURCUMINS TYR, MC1R, MITF MMP2 1633/4885MMP9 1649/4885MMP13 628/4885
US-20240360068-A1 CURCUMIN ANALOGUES AS ZINC CHELATORS AND THEIR USES NFKBIA, NFKB1, NFKB2 MMP2 19/4885MMP9 12/4885MMP13 11/4885
US-20210322346-A1 CHEMICALLY MODIFIED CURCUMINS FOR USE IN THE PRODUCTION OF LIPOXINS ALOX15B, ALOX15, ALOX12 MMP2 691/4885MMP9 1330/4885MMP13 483/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.